Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at MSEX's multiple
$69.7460.2% above market
12.37 SUPN revenue / share×5.64x MSEX P/S=$69.74
Market $43.53Implied $69.74
MSEX · current priceP/S 5.64x
$58.26Latest market snapshot
Implied fair value · at SUPN's multiple
$36.3637.6% below market
10.33 MSEX revenue / share×3.52x SUPN P/S=$36.36
Market $58.26Implied $36.36